Schwabe Pharma Asia Pacific
to top

The 13th International Congress of Asian Society Against Dementia - 13th ASAD 2019

28 Aug 2019
Dr Willmar Schwabe Pharmaceuticals (Germany) and Schwabe Pharma Asia Pacific (SPAP) collaborated to participate in the 13th Asian Society Against Dementia (ASAD) Conference 2019 in Singapore, with a central theme on “EGb 761® – A Novel Approach From Prodromal to Dementia (Critical Look into BPSD and CVD)”.